InsiderClue
Insiders · Profile

Lamb Peter

EVP, Scientific Strategy & CSO at EXELIXIS. Filing since 12 Oct 2015. CIK 0001387306

Company
Date
Role
Action
Shares
Amount
Of holding
EXEL EXELIXIS, INC.
15 Dec 2022
EVP, Scientific Strategy & CSO
Sold, plan not stated
20,000
$317.60K
4.6%
EXEL EXELIXIS, INC.
15 Dec 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
47,500
$828.40K
11.6%
EXEL EXELIXIS, INC.
15 Nov 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
47,500
$859.28K
10.4%
EXEL EXELIXIS, INC.
15 Oct 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
47,500
$1.04M
10.4%
EXEL EXELIXIS, INC.
15 Sep 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
47,500
$971.85K
10.9%
EXEL EXELIXIS, INC.
16 Aug 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
55,000
$1.01M
12.4%
EXEL EXELIXIS, INC.
15 Jul 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
60,000
$1.05M
13.3%
EXEL EXELIXIS, INC.
17 Jun 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
60,000
$1.33M
13.3%
EXEL EXELIXIS, INC.
1 Apr 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
60,000
$1.38M
13.3%
EXEL EXELIXIS, INC.
1 Mar 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
65,000
$1.44M
16.0%
EXEL EXELIXIS, INC.
1 Feb 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
65,000
$1.44M
18.7%
EXEL EXELIXIS, INC.
4 Jan 2021
EVP, Scientific Strategy & CSO
Sold, plan not stated
65,000
$1.32M
18.7%
EXEL EXELIXIS, INC.
18 Dec 2020
EVP, Scientific Strategy & CSO
Sold, plan not stated
65,000
$1.30M
18.7%
EXEL EXELIXIS, INC.
8 Jun 2020
EVP, Scientific Strategy & CSO
Sold, plan not stated
26,000
$586.56K
17.0%
EXEL EXELIXIS, INC.
7 May 2020
EVP, Scientific Strategy & CSO
Sold, plan not stated
50,000
$1.28M
28.3%
EXEL EXELIXIS, INC.
6 Apr 2020
EVP, Scientific Strategy & CSO
Sold, plan not stated
50,000
$863.00K
28.3%
EXEL EXELIXIS, INC.
18 Jun 2019
EVP, Scientific Strategy & CSO
Sold, plan not stated
100,000
$2.07M
46.0%
EXEL EXELIXIS, INC.
17 Jun 2019
EVP, Scientific Strategy & CSO
Sold, plan not stated
117,404
$2.41M
50.0%
EXEL EXELIXIS, INC.
13 Jun 2019
EVP, Scientific Strategy & CSO
Sold, plan not stated
27,596
$552.75K
19.1%
EXEL EXELIXIS, INC.
1 Mar 2017
EVP, Scientific Strategy & CSO
Sold, plan not stated
45,000
$998.55K
37.9%
EXEL EXELIXIS, INC.
1 Feb 2017
EVP, Scientific Strategy & CSO
Sold, plan not stated
70,000
$1.31M
48.7%
EXEL EXELIXIS, INC.
3 Jan 2017
EVP, Scientific Strategy & CSO
Sold, plan not stated
70,000
$1.03M
48.7%
EXEL EXELIXIS, INC.
1 Dec 2016
EVP, Scientific Strategy & CSO
Sold, plan not stated
70,000
$1.17M
48.7%
EXEL EXELIXIS, INC.
9 Nov 2016
EVP, Scientific Strategy & CSO
Sold, plan not stated
70,000
$920.50K
48.7%
EXEL EXELIXIS, INC.
16 Oct 2015
EVP, Discovery Research & CSO
Sold, plan not stated
51,549
$298.98K
58.6%
EXEL EXELIXIS, INC.
13 Oct 2015
EVP, Discovery Research & CSO
Sold, plan not stated
600
$3.48K
1.6%
EXEL EXELIXIS, INC.
12 Oct 2015
EVP, Discovery Research & CSO
Sold, plan not stated
300,276
$1.75M
89.2%
27 decisions on file.